In a notable policy shift, President Trump has reclassified state-licensed medical marijuana as a less-dangerous drug, a change that advocates have long pursued.
Legislators in Colorado and Virginia are opposing efforts to limit the powers of prescription drug affordability boards, highlighting a significant debate over drug pricing strategies.
As the Scottish Premiership title race heats up, former players Gary Locke, Ian Durrant, and Aiden McGeady provide their perspectives on the competition among Hearts, Rangers, and Celtic.
Federal regulators are set to unveil a new Medicare coverage pathway aimed at accelerating access to FDA-designated breakthrough medical devices, enhancing treatment options for patients.
In a recent shift, RFK Jr. has expressed support for vaccinations while also defending his previous secret agreements with pharmaceutical companies.
The decision by fitness chain Better to swap original music tracks for cover versions has sparked disappointment among gym-goers and instructors, who feel it diminishes class energy.
The Nuclear Energy Agency (NEA) recently convened a workshop to explore advancements and challenges in the supply of medical radioisotopes.
A recent discovery by researchers at the University of Toronto reveals that certain bacteria can transform waste into valuable chemicals, potentially transforming the cosmetics industry.
In a notable shift, Kennedy is adjusting his approach to MAHA, stepping back from several key issues while still making an impact in health care.
The appointment of a former Imperial Brands executive to a senior position at the CDC has sparked concerns about potential tobacco industry influence within the agency.
Robert F. Kennedy Jr. is set to testify before the Senate's health care panel today. Viewers can watch the proceedings live as he addresses the committee.
A recent study highlights the potential of gene therapy to restore hearing in individuals with a rare genetic form of deafness, showing effects that may last over two years.
Stay informed with the latest developments in the biotech sector, featuring updates on RevMed, Roche, and Kyverna's CAR-T therapy.
Robert F. Kennedy Jr. has made a notable return to Capitol Hill, participating in seven budget hearings over the course of a week, his first congressional testimony since September.
As summer approaches, it's essential to be aware of Vibrio, a bacteria present in coastal waters and raw shellfish, to ensure safe beach outings and seafood consumption.
The rise of MAHA snacks, from protein-infused Pop-Tarts to avocado-oil chips, suggests a shift towards healthier eating. However, nutrition experts caution that the benefits may be overstated.
Thomas Goetz emphasizes that each drug represents a broader narrative involving health, medicine, society, and economics.
The CDC’s Epidemic Intelligence Service has reached a significant milestone, having trained over 4,300 individuals who are now integral to public health efforts.
Afghan allies who supported US military efforts are reportedly facing a difficult decision: relocate to the conflict-ridden Democratic Republic of Congo or return to Taliban-controlled Afghanistan.
Roche is advancing its experimental multiple sclerosis drug to regulators following successful trials, though significant safety concerns persist.